Bladder Cancer

Analysis of real-world re-induction outcomes with nadofaragene firadenovec in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer. June 18, 2026

Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter - Beyond the Abstract June 17, 2026

Dementia and Frailty Impact Postoperative Care Trajectories and Burden among Older Adults Undergoing Radical Cystectomy for Bladder Cancer. June 17, 2026

Impact of Asymptomatic Bacteriuria on the Outcomes and Tolerability of Bacillus Calmette-Guérin Immunotherapy - Beyond the Abstract June 16, 2026

External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification Model. June 16, 2026

Automated H-Scoring in Muscle-Invasive Bladder Cancer IHC: An Internal Validation Study. June 16, 2026

Study of Bladder Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02 (RAISE-02)-A Randomized Controlled Non-Inferiority Trial. June 15, 2026

Xpert® bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial. June 15, 2026

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer. June 12, 2026

External Validation of A Decision Tree Model for Predicting Cancer-Specific Mortality After Radical Cystectomy: A Multi-Center Study in South-East Spain. June 11, 2026

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer. June 18, 2026

FGFR3 Alterations and Nectin-4 Expression as Therapeutic Biomarkers in Bladder Cancer: A Systematic Review and Single-Arm Meta-Analysis. June 17, 2026

Adoption, consistency, and usability of NICE vs EAU guidelines in low- and intermediate-risk NMIBC: a cross-sectional survey of UK urologists. June 17, 2026

HER2 and Urothelial Carcinoma: Current Understanding and Future Directions - Beyond the Abstract June 16, 2026

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability. June 16, 2026

Xpert bladder cancer detection and monitor in urothelial carcinoma: systematic review and meta-analysis. June 16, 2026

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus. June 15, 2026

A comparative analysis of variant histology and urothelial bladder cancer following radical cystectomy. June 12, 2026

Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan. June 11, 2026

Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer. June 10, 2026

Page 1 of 603